Extended-release Sodium Oxybate in Children — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Extended-release Sodium Oxybate in Children — Stella

Recruiting

Back to Narcolepsy Type 1 (NT 1) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Stanford University, Redwood City, California

Key details

Phase

Safety & dosing

Sponsor

Stanford University

Collaborators

Avadel

Enrollment target

~36 participants

Started

October 2025

Primary completion

June 2027

Age range

7 Years – 17 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov